Pharmaceutical giant Johnson & Johnson plans to start testing coronavirus vaccine in children, according to Reuters.
Reuters reported on Friday that the company will soon plan to test the test vaccine on people 12 to 18 years old.
Our country is in a historic war against Coronavirus. Add your American change to your Facebook or Twitter feed to stay up to date on news.
Jerald Sadoff, a senior adviser to the Johnson & Johnson vaccine division, said during a meeting led by the Centers for Disease Control and Prevention (CDC) Friday, according to Reuters.
Sadoff said the company also plans to test the vaccine in children under 12 if it is proven to be safe among people 12 to 18 years of age.
Most COVID-19 vaccine trials have focused on whether the shots are safe and effective in adults. Pfizer, which produced one of the four vaccine candidates currently in phase three testing in the US, recently began testing the vaccine in children.
Although much fewer children get sick with COVID-19 than adults, they can still get the virus and spread it to others.
Johnson & Johnson kicked off its third phase of vaccine trials last month, aiming to engage 60,000 participants. The company halted testing earlier this month after a participant suffered a stroke. An independent committee investigated the incident and determined the incident was not related to a vaccine, and testing was resumed this week.
It is not uncommon for some of the participants to become ill during large-scale vaccine testing, and most will continue immediately after the pause so that cases can be assessed for safety.
THINGS YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW
EXCELLENT AND SUPER LEVEL VERSION AND WHAT DO THEM MEAN FOR CORONAVIRUS?
CALIFORNIA FIRST SIMPLE FLUID AND IDENTIFICATION IN A PATIENT
USA HAS NEARS 90,000 NEW COVID-19 INFECTIONS EVERYDAY, RECORDS OF SUCH
WHAT CAN WE LEARN FROM THE SECOND CLOCK OF LIFE OF 1918
IMMUNITY AFTER THE COVID-19 INFECTION MAY LAST IN FIVE MONTHS: RESEARCH